Fatigue is one of the most prevalent and distressing symptoms of cancer, and is a common
side-effect of many of the treatments available for the management of malignant disease. We …

Despite the high prevalence of cancer-related fatigue and its documented negative effects
on patients' quality of life, limited evidence is available to support interventions to prevent or …

Fatigue is one of the most common complaints of people with cancer. It affects the majority of
patients actively undergoing cancer related therapies, but also a meaningful number of …

Fatigue is the most prevalent cancer-related symptom and has a significant adverse impact
on patients' functional ability and quality of life. Hypotheses regarding the aetiology of …

Fatigue is a common symptom in patients with cancer and in disease-free survivors. It has a
significant impact on the quality of life. Although subjective fatigue is often related to …

This paper reviews current knowledge regarding cancer-related fatigue assessment,
prevalence, mechanisms and management. Most quality of life questionnaires contain at …

Fatigue is one of the most common adverse effects of cancer that might persist for years after
treatment completion in otherwise healthy survivors. Cancer-related fatigue causes …

Answer questions and earn CME/CNE Evidence regarding cancer‐related fatigue (fatigue)
has accumulated sufficiently such that recommendations for screening, evaluation, and/or …

Cancer fatigue and exercise fatigue months or years (average 471 days) after chemotherapy
had ended. Fatigue can also occur after autologous bone-marrow transplantation14 or after …

Opinion statement Cancer-related fatigue (CRF) is a problem for a significant proportion of
cancer survivors during and after active cancer treatment. However, CRF is underdiagnosed …